Sterling Investment Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,089
Closed -$462K 68
2025
Q4
$462K Sell
9,089
-10,857
-54% -$555K 0.26% 56
2025
Q3
$1.11M Buy
19,946
+6,102
+44% +$357K 0.66% 40
2025
Q2
$956K Buy
+13,844
New +$942K 0.63% 41

Other funds holding NVO

Sterling Investment Management's NVO Position: Q1 2026 in Review

Sterling Investment Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 9,089 shares — an estimated $462K sold.

Sterling Investment Management first reported a position in NVO in Q2 2025 and held it in 3 quarters. The position peaked at $1.11M in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Sterling Investment Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Sterling Investment Management sold 9,089 Novo Nordisk shares in Q1 2026, an estimated $462K.
  • Sterling Investment Management first reported a position in Novo Nordisk in Q2 2025 and held it in 3 quarters.
  • Sterling Investment Management's Novo Nordisk position peaked at $1.11M in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Sterling Investment Management's 13F filing for Q1 2026, filed 4 May 2026.